Myovant Sciences (MYOV) 10-Q2023 Q1 Quarterly report

Filed: 27 Jul 22, 4:18pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: accustomed, adapt, Africa, ago, androgen, banker, BMA, breakdown, broader, CamceviTM, category, cautionary, chairperson, constraint, corroborated, COVID, devalue, disagree, dissatisfaction, diversification, Donetsk, East, EC, electronic, Embryology, engineering, ESHRE, Eurasia, evacuation, explain, explanation, flow, forward, fuel, hospital, hybrid, hypothetical, incident, India, inflationary, judgement, knowledge, Lancet, likelihood, Luhansk, macroeconomic, MAP, meantime, Middle, military, minimum, mobile, monotherapy, movement, MSI, network, obsolescence, OECD, onsite, ORILISSA, partly, PDUFA, purpose, ransomware, reopen, reopened, retaliatory, reversal, rounding, Russian, RWS, stricter, sum, susceptible, TCJA, threshold, traditional, transportation, treaty, Turkey, Ukraine, uncollectible, underinsured, understand, understood, unmet, USPI, violence, virtue, vulnerable, warfare, website

Removed: AAGL, accounted, ACOG, Adele, affiliate, allocate, ASCO, ASRM, AUA, begun, borrowed, capitalizing, Chief, Commensurate, continually, delivered, delivering, denominated, depleted, distinct, efficiency, exercisable, exercised, expired, feature, focused, fourth, franc, functional, Gulfo, improve, jurisdictional, methodology, modestly, NCCN, percent, procuring, reclassified, redefining, refusal, remeasured, represented, repurchase, settled, Simplifying, substantive, taxed, unvested, vested

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

MYOV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Myovant Sciences Ltd. (the “Company”) for the period ended June 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Uneek Mehra, Principal Financial Officer of the Company, hereby certifies, pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and 18 U.S.C. Section 1350, that to the best of his knowledge:

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: July 27, 2022	By:	/s/ Uneek Mehra
		Uneek Mehra
		Principal Financial Officer

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.